1422 related articles for article (PubMed ID: 15692726)
1. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis.
Richy F; Schacht E; Bruyere O; Ethgen O; Gourlay M; Reginster JY
Calcif Tissue Int; 2005 Mar; 76(3):176-86. PubMed ID: 15692726
[TBL] [Abstract][Full Text] [Related]
2. Importance of alfacalcidol in clinical conditions characterized by high rate of bone loss.
Reginster JY; Lecart MP; Richy F
J Rheumatol Suppl; 2005 Sep; 76():21-5. PubMed ID: 16142847
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of D-hormone analogs and native vitamin D on the risk of falls: a comparative meta-analysis.
Richy F; Dukas L; Schacht E
Calcif Tissue Int; 2008 Feb; 82(2):102-7. PubMed ID: 18239843
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate.
Richy F; Ethgen O; Bruyere O; Reginster JY
Osteoporos Int; 2004 Apr; 15(4):301-10. PubMed ID: 14740153
[TBL] [Abstract][Full Text] [Related]
5. Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosis.
Ringe JD; Faber H; Fahramand P; Schacht E
J Rheumatol Suppl; 2005 Sep; 76():33-40. PubMed ID: 16142849
[TBL] [Abstract][Full Text] [Related]
6. Combined therapies in osteoporosis: bisphosphonates and vitamin D-hormone analogs.
Schacht E; Dukas L; Richy F
J Musculoskelet Neuronal Interact; 2007; 7(2):174-84. PubMed ID: 17627088
[TBL] [Abstract][Full Text] [Related]
7. Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium.
Sambrook PN; Kotowicz M; Nash P; Styles CB; Naganathan V; Henderson-Briffa KN; Eisman JA; Nicholson GC
J Bone Miner Res; 2003 May; 18(5):919-24. PubMed ID: 12733733
[TBL] [Abstract][Full Text] [Related]
8. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 8. Vitamin D metabolites and analogs in the treatment of osteoporosis.
Jones G; Hogan DB; Yendt E; Hanley DA
CMAJ; 1996 Oct; 155(7):955-61. PubMed ID: 8837546
[TBL] [Abstract][Full Text] [Related]
9. The therapeutic effects of alfacalcidol on bone strength, muscle metabolism and prevention of falls and fractures.
Schacht E; Richy F; Reginster JY
J Musculoskelet Neuronal Interact; 2005; 5(3):273-84. PubMed ID: 16172518
[TBL] [Abstract][Full Text] [Related]
10. Prevention of bone loss and vertebral fractures in patients with chronic epilepsy--antiepileptic drug and osteoporosis prevention trial.
Lazzari AA; Dussault PM; Thakore-James M; Gagnon D; Baker E; Davis SA; Houranieh AM
Epilepsia; 2013 Nov; 54(11):1997-2004. PubMed ID: 24010637
[TBL] [Abstract][Full Text] [Related]
11. Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial).
Ringe JD; Farahmand P; Schacht E; Rozehnal A
Rheumatol Int; 2007 Mar; 27(5):425-34. PubMed ID: 17216477
[TBL] [Abstract][Full Text] [Related]
12. The role of vitamin D in corticosteroid-induced osteoporosis: a meta-analytic approach.
Amin S; LaValley MP; Simms RW; Felson DT
Arthritis Rheum; 1999 Aug; 42(8):1740-51. PubMed ID: 10446876
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men.
Avenell A; Mak JC; O'Connell D
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD000227. PubMed ID: 24729336
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis.
Avenell A; Gillespie WJ; Gillespie LD; O'Connell DL
Cochrane Database Syst Rev; 2005 Jul; (3):CD000227. PubMed ID: 16034849
[TBL] [Abstract][Full Text] [Related]
15. Potential of alfacalcidol for reducing increased risk of falls and fractures.
Ringe JD; Schacht E
Rheumatol Int; 2009 Aug; 29(10):1177-85. PubMed ID: 19159932
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis.
Gillespie WJ; Henry DA; O'Connell DL; Robertson J
Cochrane Database Syst Rev; 2000; (2):CD000227. PubMed ID: 10796331
[TBL] [Abstract][Full Text] [Related]
17. Strontium: new drug. Postmenopausal osteoporosis: too many unknowns.
Prescrire Int; 2005 Dec; 14(80):207-11. PubMed ID: 16397977
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis.
Avenell A; Gillespie WJ; Gillespie LD; O'Connell D
Cochrane Database Syst Rev; 2009 Apr; (2):CD000227. PubMed ID: 19370554
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study.
Reid DM; Hughes RA; Laan RF; Sacco-Gibson NA; Wenderoth DH; Adami S; Eusebio RA; Devogelaer JP
J Bone Miner Res; 2000 Jun; 15(6):1006-13. PubMed ID: 10841169
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and safety of vitamin D in relation to bone health.
Cranney A; Horsley T; O'Donnell S; Weiler H; Puil L; Ooi D; Atkinson S; Ward L; Moher D; Hanley D; Fang M; Yazdi F; Garritty C; Sampson M; Barrowman N; Tsertsvadze A; Mamaladze V
Evid Rep Technol Assess (Full Rep); 2007 Aug; (158):1-235. PubMed ID: 18088161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]